The DOGE Shock: Nine Stocks to Buy

They say that DOGE's real agenda could shock the entire stock market in the coming days - sending a handful of widely unknown stocks soaring. And they've compiled the definitive investment playbook for anyone who wants the opportunity to capitalize.

Eventful Monday For AstraZeneca - What's Going On?

Vandana Singh
March 17, 2025

On Monday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the CALYPSO Phase 3 trial designed to evaluate the efficacy and safety of eneboparatide in adults with chronic hypoparathyroidism.

The study showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary endpoint with statistical significance at 24 weeks in adults with chronic hypoparathyroidism (HypoPT) compared to placebo.

The primary endpoint is a composite of normalization of albumin-adjusted serum calcium levels and independence from active vitamin D and oral calcium therapy.

Also Read: AstraZeneca’s Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients

HypoPT is a rare endocrine disease caused by a deficiency of PTH and is characterized by impaired regulation of calcium and phosphate levels in the blood. Eneboparatide was well tolerated.

After the 24-week randomized treatment period, all patients receive eneboparatide in the ongoing long-term extension until 52 weeks. Full efficacy and safety data will be analyzed at 52 weeks.

Concurrently, AstraZeneca and Alteogen entered into an exclusive license agreement for ALT-B4, a hyaluronidase utilizing Hybrozyme platform technology.

Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialize subcutaneous formulations of several oncology assets.

Alteogen will be responsible for the clinical and commercial supply of ALT-B4 to AstraZeneca.

AstraZeneca will pay Alteogen an upfront payment and additional payments upon achieving specific development, regulatory, and sales-related milestones. Additionally, Alteogen will receive royalties on the sales of the commercialized products.

On Monday, the European Union approved AstraZeneca’s Imfinzi (durvalumab) as monotherapy for adults with limited-stage small cell lung cancer whose disease has not progressed following platinum-based chemoradiation therapy.

The approval is based on results from the ADRIATIC Phase 3 trial.

The trial showed that Imfinzi reduced the risk of death by 27% compared to placebo.

The estimated median overall survival was 55.9 months for Imfinzi versus 33.4 months for placebo. An estimated 57% of patients treated with Imfinzi were alive at three years compared to 48% for placebo.

Imfinzi also reduced the risk of disease progression or death by 24% versus placebo.

The median progression-free survival (PFS) was 16.6 months for Imfinzi versus 9.2 months for placebo. An estimated 46% of patients treated with Imfinzi had not experienced disease progression at two years compared to 34% for placebo.

Earlier on Monday, AstraZeneca agreed to acquire cell therapy focused-EsoBiotec SA for up to $1 billion.

Price Action: At the last check on Monday, AZN stock was down 1.04% to $76.78 during the premarket session.

Read Next:

  • Hain Celestial Valuation Is Low Versus Historical Levels, But Analyst Remains Neutral – Here’s Why

Image by Robert Way via Shutterstock

Continue Reading...

Popular

Eaton's Growth Targets Look Achievable, Analyst Raises EPS Forecast For 2026 & 2027

Analyst reaffirms Buy rating on Eaton with $410 price target after investor day. Expects strong growth in data centers, commercial, utilities, and aerospace.

TON Token Value Soars 20% As Telegram Founder Pavel Durov Regains Passport From French Authorities

The TON (CRYPTO: TON) token has witnessed a significant surge in value, following the recovery of Telegram founder Pavel Durov‘s passport from French authorities.

The "Second Wave" of 2025 Crashes (Could Be Worst in Us History) - Ad

According to the man who predicted 2008, 2020, and 2022... A new wave of crashes are coming to the US stock market. But these will be different. The moment they hit, they could kick off the worst (and longest) financial crisis in American history.

Charlie Munger's Timeless Investment Advice: Sidestep These Three Common Missteps

In a world of ever-changing investment landscapes, the enduring wisdom of the late investment expert and Warren Buffett's partner, Charlie Munger, continues to guide investors towards better investment results.

Trump, Musk, and Democrats Get Low Marks on Economy in NBC Poll

In a new poll, President Trump, Elon Musk, and the Democratic Party all received poor marks on the economy.

Why Trump's Recent Moves Could Ignite a New Gold Standard - Ad

Donald Trump's bold policies are driving a hidden gold market boom. Garrett Goggin, a renowned precious metals expert with 20+ years of experience, reveals 5 explosive investment opportunities set to explode in this new era. Backed by triple-digit returns in 2024, Garrett's insights show you how to position yourself for wealth in 2025.

NBA Legend Shaq's Walmart Shopping Spree Ends In Credit Card Decline - Here's How Much He Tried To Spend

Basketball superstar Shaquille O'Neal's impact goes beyond basketball, with his larger-than-life personality and smart investments. Yet, one of his most unforgettable moments happened at Walmart.

Wall Street Legend Now Calling Exact Day Next Market Crash Will Start? - Ad

Perhaps no one on or off Wall Street has more accurate in calling the market turns of the past 7 years. From the bear markets of 2018 and 2022... to the roaring bull runs of 2021, 2023, and 2024. And now, Marc Chaikin is predicting the exact month (even the exact day!) the next crash is most likely to start--don't miss this huge and important new call.

Law firm sues over Trump executive order that seeks to suspend security clearances

WASHINGTON (AP) — A during the 2016 presidential campaign sued the federal government Tuesday over an executive order that seeks to strip its attorneys of security clearances.

Meet the federal worker who went rogue: I hope that it lights a fire under people

NEW YORK (AP) — To billionaire Elon Musk and his cost-cutting team at the Department of Government Efficiency, Karen Ortiz may just be one of many faceless bureaucrats. But to some of her colleagues, she is giving a voice to those who feel they can't speak out.

AI + Smart Glass = A Nasdaq Sleeper - Ad

This recent Nasdaq IPO is quietly making waves, thanks to its 95% market share in a $240M aerospace niche. With patented technology that integrates AI into smart glass, this company is poised for massive growth as the market races toward $124 billion by 2029.

Bill Gates' Next Big AI Bet: Stargate Could Be a Game-Changer - Ad

Jeff Brown, the tech expert who predicted Bitcoin, Nvidia, and Tesla, reveals Bill Gates' new AI project, Stargate. Could this be the next big AI breakthrough?

Warren Buffett on Debt and Donald Trump's Money Moves: Trump 'Never Went Right'

In a piece of advice that continues to hold relevance, investor Warren Buffett once warned students about the perils of excessive borrowing, citing Donald Trump as a case in point.

Canada's Liberals will elect new leader to replace Trudeau as country deals with Trump's trade war

TORONTO (AP) — Canada's governing Liberals will announce a replacement for Prime Minister on Sunday as the country deals with U.S. President Donald Trump's and as a federal election looms.

Millionaire Trader: "My No. 1 Stock of the Decade" (Revealed Free) - Ad

The stock revealed right here just may be millionaire trader Jeff Clark's favorite stock ever. Because this one stock alone has been responsible for some of the biggest gains he's ever handed my readers... 195% in under a month... 85% in 14 days... 176% in 5 weeks... 120% in under 3 months... 55% in two days... 138% in 8 days... And even 222% in 8 days.

Tesla's China Boom, Rivian's Sweet Ride, And Trump's Tariffs Threat: This Week In Mobility

The EV industry saw major developments over the weekend, with Tesla's Model Y surging in China, its Model S/X retreating from Japan, Rivian unveiling its Georgia timeline and an ice cream truck partnership, and Trump's tariffs threatening the profits of Detroit's Big Three automakers.

The Fort Knox Cover-up? What It Means for Gold - Ad

Trump and Musk are demanding answers: Is Fort Knox empty? If the gold is gone, supply collapses, and prices could skyrocket instantly. Right now, I've uncovered 5 major gold predictions that could make this Fort Knox moment even bigger than people realize. One of them is already unfolding--and the window to act is closing fast.

Mohamed El-Erian Says 'Fed Put' Optimism Rises As Inflation Cools - But 'Trump Put' Hopes Are Shaken

U.S. markets rallied on Wednesday after February's inflation report came in softer than anticipated, bolstering expectations for Federal Reserve rate cuts while investors reassess the economic impact of President Donald Trump administration's policies.

Melinda French Gates Reveals An IBM Manager Inspired Her To Join Bill Gates Co-Founded 'Little Company' Microsoft

Melinda French Gates credited a conversation with an IBM (NYSE: IBM) hiring manager for her decision to join Microsoft (NASDAQ: MSFT), a choice that significantly impacted her career and personal life.

The Gold Shift No One's Talking About - Yet - Ad

Massive gold shipments are quietly moving from London to the U.S.--no headlines, no explanations. Could a full-scale audit or a new gold-backed system be coming? Smart money isn't waiting. My gold strategy is already doubling physical gold's returns this year.

AOC Claps Back At Mike Johnson As Senate Moves Closer To Government Shutdown: 'If You Need Democrats, Then You Need To Negotiate'

Alexandria Ocasio-Cortez pushed back on Speaker Mike Johnson's blame for a possible shutdown, reminding him that Republicans control the government and must negotiate if they lack the votes.

Who is Mark Carney, the next prime minister of Canada?

TORONTO (AP) — Former central banker Mark Carney will become Canada’s next prime minister after a Liberal Party leadership vote in a landslide.

Just Released: Huge New A.I. Trade - Ad

While everyone's distracted by Nvidia, PLTR & Bitcoin, billionaires have been quietly loading up on this stock. And 99% of Americans have no clue. It could help make a fortune for fast-moving investors, who make their move before March 19.

Critics warn staff cuts at federal agencies overseeing US dams could put public safety at risk

COULEE DAM, Wash. (AP) — Trump administration workforce cuts at federal agencies overseeing U.S. dams are threatening their ability to provide reliable electricity, supply farmers with water and protect communities from floods, employees and industry experts warn.

Here's what tariffs are and how they work

WASHINGTON (AP) — Tariffs are in the news at the moment. Here's what they are and what you need to know about them:

The Last Time Gold Flashed This Warning Sign, the Market Dropped 80% - Ad

Both President Trump and Elon Musk are warning about something that could send the market down 50%, real estate down 40% and savings accounts down 30%.

What's Going On With Gap Stock Friday?

Gap stock is trading higher on Friday after the company reported fourth-quarter earnings on Thursday after the market closed.

Intel Beats Investor Lawsuit After $32 Billion Stock Plunge - Judge Rules Foundry Losses Weren't Misleading

Intel secured a legal victory after a U.S. judge dismissed a shareholder lawsuit alleging the company misled investors about foundry losses, which contributed to a $32 billion stock plunge.

A Uranium Boom Is Coming--Are You Positioned? - Ad

The last uranium cycle created massive winners. This new bull market is just beginning, and one tiny uranium stock could be a major beneficiary.

Japan's Seven & i sells retail business to Bain Capital for $5.4 billion, plans IPO

Japan’s Seven & i, the parent company of the Japanese 7-Eleven convenience store chain, said Thursday it is selling its supermarket store assets to Bain Capital for about $5.4 billion.

The $20 Trillion Secret of Room 3330 - Ad

Developed by the U.S. military 79 years ago, this controversial technology is about to change American life forever: Elon Musk has already funneled $6 billion to resurrect this covert project -- and the companies involved are minting 10,000 millionaires every week [Goldman Sachs].

Chuck Schumer Blames GOP For 'Partisan Path' As Shutdown Nears - Republicans Say 'Democrats' Fault' If Government Closes

Congressional leaders exchanged sharp criticisms Wednesday as the federal government faces a potential shutdown within days, highlighting the partisan divide over spending priorities and negotiation tactics.

China's foreign minister blasts the US over tariffs at his annual meeting with journalists

TAIPEI, Taiwan (AP) — Along with against the United States, China’s Foreign Minister Wang Yi reasserted China’s South China Sea claims, blasted Japan for its past aggression and covered a wide range of other issues during his annual meeting with the press. Here are some of the key topics covered during his Friday press conference.

Three New Patents Reveal Elon and Trump's Secret "Project America" - Ad

Three patents could help President Trump and Elon Musk completely revolutionize a $23 Trillion market. This revolution is about so much more than just self-driving cars. Instead, what Elon's pivoting Tesla towards... Is a market that's 1,000X BIGGER. But a project THIS big can't stay under the radar for long...

Trump vs Musk? Federal Workers Unconvinced He'll Take Action: 'If They Don't Cut, Elon will, Comments Show Who's Really In Charge'

President Donald Trump has reportedly limited the authority of his billionaire advisor, Elon Musk, to dismiss federal employees. This development has stirred skepticism among the workforce and political circles.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service